AIM logo

AIM ImmunoTech Inc. (AIM)

Profile

Full Name

AIM ImmunoTech Inc.

Ticker

NYSEAmerican: AIM

Exchange

NYSE American

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

July 12, 1996

Indexes

Not included

Website

https://aimimmuno.com

Employees

21

Key Details

Price

$2.36(-10.94%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$170.00K(-15.84% YoY)

Annual EPS

-$31.00(-5066.67% YoY)

PE ratio

-

Next earnings date

N/A

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $2.36
    AIM price is $2.36

    30-Day Relative Volume

    0.44
    AIM 30-day relative volume is 0.44

    Price Performance

    Price Most recent change

    -10.94%
    AIM price was down -10.94% on Aug 18, 2025

    Price YTD change

    -88.2%
    AIM price is down -88.2% since January 1st

    Price 1-year change

    -92.13%
    AIM price is down -92.13% year-on-year

    Price 3-year change

    -96.77%
    AIM price is down -96.77% over the past 3 years

    Price Range

    Price All-time high

    $1.00M
    AIM price is currently -100.00% below its historical high of $1.00 million

    Price 3-year low

    $2.35
    AIM price is currently +0.43% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $1.80M
    AIM market capitalization is $1.80 million

    Market cap 3-year change

    -94.86%
    AIM market capitalization is down -94.86% over the past 3 years

    Market cap All-time high

    $49.74B
    AIM market capitalization is currently -100.00% below its historical high of $49.74 billion

    Market cap sector rank

    4.98%
    AIM market capitalization is higher than 4.98% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +33.74%
    AIM shares outstanding is up +33.74% year-on-year

    Shares Outstanding 3-Year Change

    +59.04%
    AIM shares outstanding is up +59.04% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.19
    AIM beta is 1.19

    200-day SMA

    $13.11
    AIM price is currently -82.00% below its 200-day simple moving average

    50-day SMA

    $6.87
    AIM price is currently -65.67% below its 50-day simple moving average

    RSI

    21.98
    AIM 14-day relative strength index is 21.98

    Volume

    0.44
    AIM 30-day relative volume is 0.44

    ATR

    $0.66
    AIM average true range is $0.66

    10-day Historical Volatility

    72.23%
    AIM 10-day historical volatility is 72.23%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $170.00K
    AIM annual revenue is $170.00 thousand

    Revenue Analysts estimate

    $200.00K
    AIM annual revenue is currently -15.00% lower than the consensus analysts' forecast

    Revenue 1-year change

    -15.84%
    AIM annual revenue is down -15.84% year-on-year

    Revenue Sector rank

    32.29%
    AIM annual revenue is higher than 32.29% of companies in Healthcare sector

    EPS

    EPS

    -$31.00
    AIM annual earnings per share is -$31.00

    EPS Analysts estimate

    -$31.00
    AIM annual earnings per share is currently equal to the consensus analysts' forecast

    EPS 1-year change

    -5066.67%
    AIM annual earnings per share is down -5066.67% year-on-year

    EPS Sector rank

    5.39%
    AIM annual earnings per share is higher than 5.39% of companies in Healthcare sector

    Profit

    Gross profit

    -$107.00K
    AIM annual gross profit is -$107.00 thousand

    Gross margin

    -62.94%
    AIM annual gross profit margin is -62.94%

    Operating profit

    -$19.77M
    AIM annual operating income is -$19.77 million

    Operating margin

    -11.63K%
    AIM annual operating profit margin is -11.63 thousand%

    Net income

    -$17.32M
    AIM annual net profit is -$17.32 million

    Net margin

    -10.19K%
    AIM annual net profit margin is -10.19 thousand%

    Expenses

    Total expenses

    $19.94M
    AIM annual total expenses is $19.94 million

    Operating expenses

    $19.91M
    AIM annual total operating expenses is $19.91 million

    Cost of goods sold

    $277.00K
    AIM annual cost of goods sold is $277.00 thousand

    Selling, general & administrative expenses

    $13.71M
    AIM annual SGA is $13.71 million

    Depreciation and amortization

    $246.00K
    AIM annual depreciation & amortization is $246.00 thousand

    Interest expense

    $0.00
    AIM annual interest expense is $0.00

    Income tax

    $0.00
    AIM annual income tax is $0.00

    EBIT & EBITDA

    EBIT

    -$16.73M
    AIM annual earnings before interest & taxes is -$16.73 million

    EBITDA

    -$16.49M
    AIM annual EBITDA is -$16.49 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $51.49M
    AIM annual total assets is $51.49 million

    Non current assets

    $4.43M
    AIM annual long term assets is $4.43 million

    Current assets

    $4.18M
    AIM annual total current assets is $4.18 million

    Cash and cash equivalents

    $1.70M
    AIM annual cash & cash equivalents is $1.70 million

    Accounts receivable

    -
    AIM annual accounts receivable value is unknown

    Inventory

    $0.00
    AIM annual inventory is $0.00

    Liabilities

    Total liabilities

    $52.81M
    AIM annual total liabilities is $52.81 million

    Long term liabilities

    $42.88M
    AIM annual total long term liabilities is $42.88 million

    Current liabilities

    $9.54M
    AIM annual total current liabilities is $9.54 million

    Accounts payable

    $6.38M
    AIM annual accounts payable is $6.38 million

    Debt

    Total debt

    $2.94M
    AIM annual total debt is $2.94 million

    Total debt 1-year change

    +309.61%
    AIM annual total debt is up +309.61% year-on-year

    Long term debt

    $395.00K
    AIM annual long term debt is $395.00 thousand

    Short term debt

    $2.55M
    AIM annual short term debt is $2.55 million

    Equity & Capital

    Shareholders equity

    -$1.32M
    AIM annual stockholders equity is -$1.32 million

    Book value

    -$1.32M
    AIM annual book value is -$1.32 million

    Retained earnings

    -$426.83M
    AIM annual retained earnings is -$426.83 million

    Working capital

    -$5.36M
    AIM annual working capital is -$5.36 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$14.89M
    AIM annual cash flow from operations is -$14.89 million

    Cash from operations 1-year change

    +29.99%
    AIM annual cash flow from operations is up +29.99% year-on-year

    Cash from investing

    $4.71M
    AIM annual cash flow from investing activities is $4.71 million

    Cash from investing 1-year change

    +665.62%
    AIM annual cash flow from investing activities is up +665.62% year-on-year

    Cash from financing

    $6.44M
    AIM annual cash flow from financing activities is $6.44 million

    Cash from financing 1-year change

    +1228.66%
    AIM annual cash flow from financing activities is up +1228.66% year-on-year

    CAPEX

    CAPEX

    $556.00K
    AIM annual capital expenditures is $556.00 thousand

    CAPEX 1-year change

    -4.96%
    AIM annual capital expenditures is down -4.96% year-on-year

    Free Cash Flow

    Free cash flow

    -$15.44M
    AIM annual free cash flow is -$15.44 million

    Free cash flow 1-year change

    +29.32%
    AIM annual free cash flow is up +29.32% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    -62.94%
    AIM annual gross profit margin is -62.94%

    Operating margin

    -11.63K%
    AIM annual operating profit margin is -11.63 thousand%

    Net margin

    -10.19K%
    AIM annual net profit margin is -10.19 thousand%

    ROA & ROE

    ROA

    -48.85%
    AIM annual return on assets is -48.85%

    ROE

    -388.69%
    AIM annual return on equity is -388.69%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    AIM price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    AIM price to earnings ratio is unknown

    PB Ratio

    PB ratio

    -0.28
    AIM price to book ratio is -0.28

    PB ratio Sector rank

    12.8%
    AIM price to book ratio is higher than 12.8% of companies in Healthcare sector

    PS Ratio

    PS ratio

    14.91
    AIM price to sales ratio is 14.91

    PS ratio Sector rank

    78.53%
    AIM price to sales ratio is higher than 78.53% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $968.51K
    AIM enterprise value is $968.51 thousand

    Enterprise value Sector rank

    16.61%
    AIM enterprise value is higher than 16.61% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -0.06
    AIM EV/EBITDA is -0.06

    EV/EBITDA Sector rank

    58.9%
    AIM EV/EBITDA is higher than 58.9% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    0.44
    AIM annual current ratio is 0.44

    Quick ratio

    0.44
    AIM annual quick ratio is 0.44

    Leverage

    Debt to equity

    -1.75
    AIM annual debt to equity ratio is -1.75

    Interest coverage ratio

    -
    AIM annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    -
    AIM piotroski f-score value is unknown

    Altman Z-Score

    -12.78
    AIM altman z-score is -12.78

    Analyst ratings

    Recent major analysts updates

    Dec 10, 24 Ascendiant Capital
    Buy
    Oct 22, 24 Maxim Group
    Buy
    Sep 3, 24 Ascendiant Capital
    Buy
    Oct 10, 19 Maxim Group
    Buy

    Institutional Ownership

    Screeners with AIM included

    Growing Shares Outstanding
    US stocks
    Stocks with high beta
    Stocks below SMA 200
    Most recommended stocks
    Stocks below analysts price target
    Healthcare sector
    All stocks
    Biotech Companies
    Ex Dividend dates calendar
    • What is the ticker symbol for AIM ImmunoTech Inc.?
    • Does AIM ImmunoTech Inc. pay dividends?
    • What sector is AIM ImmunoTech Inc. in?
    • What industry is AIM ImmunoTech Inc. in?
    • What country is AIM ImmunoTech Inc. based in?
    • When did AIM ImmunoTech Inc. go public?
    • Is AIM ImmunoTech Inc. in the S&P 500?
    • Is AIM ImmunoTech Inc. in the NASDAQ 100?
    • Is AIM ImmunoTech Inc. in the Dow Jones?
    • When was AIM ImmunoTech Inc.'s last earnings report?
    • When does AIM ImmunoTech Inc. report earnings?

    What is the ticker symbol for AIM ImmunoTech Inc.?

    The ticker symbol for AIM ImmunoTech Inc. is NYSEAmerican:AIM

    Does AIM ImmunoTech Inc. pay dividends?

    No, AIM ImmunoTech Inc. does not pay dividends

    What sector is AIM ImmunoTech Inc. in?

    AIM ImmunoTech Inc. is in the Healthcare sector

    What industry is AIM ImmunoTech Inc. in?

    AIM ImmunoTech Inc. is in the Biotechnology industry

    What country is AIM ImmunoTech Inc. based in?

    AIM ImmunoTech Inc. is headquartered in United States

    When did AIM ImmunoTech Inc. go public?

    AIM ImmunoTech Inc.'s initial public offering (IPO) was on July 12, 1996

    Is AIM ImmunoTech Inc. in the S&P 500?

    No, AIM ImmunoTech Inc. is not included in the S&P 500 index

    Is AIM ImmunoTech Inc. in the NASDAQ 100?

    No, AIM ImmunoTech Inc. is not included in the NASDAQ 100 index

    Is AIM ImmunoTech Inc. in the Dow Jones?

    No, AIM ImmunoTech Inc. is not included in the Dow Jones index

    When was AIM ImmunoTech Inc.'s last earnings report?

    AIM ImmunoTech Inc.'s most recent earnings report was on August 15, 2025

    When does AIM ImmunoTech Inc. report earnings?

    The date for AIM ImmunoTech Inc.'s next earnings report has not been announced yet
    On this page